“Beyond Drug Discovery: Implementing Internal Changes on the Business and Clinical Sides of Pharma”, addresses key organizational challenges faced by pharmaceutical companies in managing internal changes. It emphasizes the critical need for structured change management processes to overcome common barriers such as risk-averse cultures, lack of leadership skills, unclear accountability, and insufficient project management resources for non-drug initiatives. The content highlights the distinction between "Installation" and "Implementation," explaining how technical deployments often fail due to limited focus on the human elements of change, impacting adoption and optimization. By advocating for robust change readiness strategies, the document underscores the importance of engaging skilled change agents, reinforcing sponsors, and localized expertise to achieve full optimization and value realization. This is ideal for B2B companies in the pharmaceutical sector looking to streamline operations, sustain innovation, and drive measurable change outcomes.